Related Experiment Video
Updated: May 23, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Trends and Disparities in Rates of Hypoglycemia Among Hospitalized Patients With Type 2 Diabetes
Paul A Heidenreich1,2, Shoutzu Lin1, Robert J Gallo1,3
1VA Palo Alto Health Care System, Palo Alto, CA.
Objective:
Hypoglycemia is a common complication of inpatient care for patients with diabetes. We sought to determine recent trends and demographic disparities in the rate of inpatient hypoglycemia.
Research Design And Methods:
We used data from the Veterans Affairs (VA) health care system to identify all patients with type 2 diabetes hospitalized from 2016 to 2022. We determined rates of inpatient hypoglycemia (<70 mg/dL) and discharge diagnosis coding for hypoglycemia. We determined differences in rates of hypoglycemia by age, sex, and race and ethnicity, adjusting for other patient diagnoses, laboratory values, vital signs, and insulin use.
Results:
Among 512,261 patients hospitalized with diabetes, 6.8% (34,918) had an episode of hypoglycemia (<70 mg/dL). This rate decreased by 17% from 2016 to 2022 (7.4% to 6.3%), while the rate of discharge diagnosis among those with hypoglycemia increased. After adjustment for other patient characteristics, the youngest and oldest patients, and those hospitalized in earlier years (vs. 2022) had significantly higher rates of hypoglycemia. Black (adjusted odds ratio [aOR] 1.42, 95% CI 1.36-1.49) or Hispanic patients (aOR 1.26, 95% CI 1.17-1.35) had a greater risk of hypoglycemia compared with non-Hispanic White patients, and women had borderline less hypoglycemia than men (aOR 0.95, 95% CI 0.89-1.00).
Conclusions:
Inpatient hypoglycemia in the VA health system has been declining, although there are race, age, and sex differences that remain unexplained. Recognition of hypoglycemia, defined as a discharge diagnosis, is increasing.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...